PRAGUE — At the European Glaucoma Society Congress, Ingeborg Stalmans, MD, PhD, shares positive 1-year interim data from the ongoing phase 4 clinical trial of AqueSys/Allergan’s Xen45 gel stent.

Full Story →

PRAGUE — At the European Glaucoma Society Congress, Ingeborg Stalmans, MD, PhD, shares positive 1-year interim data from the ongoing phase 4 clinical trial of AqueSys/Allergan’s Xen45 gel stent.

Full Story →